Key result
Type 2 diabetes was associated with reduced heart rate variability and increased subclinical atherosclerosis, with CIMT inversely associated with total power.
Why the study?
Is cardiac autonomic neuropathy associated with markers of subclinical atherosclerosis in patients with early type 2 diabetes?
Observational (n=111)
Is cardiac autonomic neuropathy associated with markers of subclinical atherosclerosis in patients with early type 2 diabetes?
Cardiac autonomic neuropathy is present in early T2DM and is independently associated with subclinical atherosclerosis markers such as increased CIMT.
Answers are grounded in this paper and cite their sources.
May link autonomic neuropathy to atherosclerosis risk in early T2DM; hypothesis-generating and requires prospective validation.
Cardiac autonomic neuropathy (CAN) is a critical complication of type 2 diabetes mellitus (T2DM). Heart rate variability (HRV) is a noninvasive tool to assess cardiac autonomic function. We aimed to evaluate whether CAN is associated with increased risk of atherosclerosis in T2DM. A total of 57 diabetic and 54 nondiabetic subjects, free of coronary heart disease, were recruited. Carotid intima media thickness (CIMT), coronary calcium score (CAC), and brachial Flow Mediated Dilation (FMD) were measured. Heart rate variability and vagal components of autonomic function were determined. Significant reduction of normalized HF power (P < 0.05) and total power (P < 0.01) was observed in T2DM. CIMT and CAC scores were significantly higher while FMD was significantly lower in diabetics (P < 0.01 for all). Median HbA(1c) levels were significantly higher in diabetics. CIMT was inversely and independently associated with total power both in diabetics and controls (P < 0.01 for both groups). There was also an inverse association between total power and median HbA(1c). Autonomic dysfunction, especially parasympathetic neuropathy, was present since early-stage T2DM. This was related to subclinical atherosclerosis. Early detection of cardiac autonomic neuropathy can help us detect the development of atherosclerosis earlier in T2DM to prevent unfavorable outcomes.
No takes yet. Share an insight, caveat, or question.
Fakhrzadeh et al. (2012) conducted an observational in Type 2 diabetes mellitus (n=111). Type 2 diabetes mellitus vs. Nondiabetic subjects was evaluated on Heart rate variability (normalized HF power and total power) and markers of subclinical atherosclerosis (CIMT, CAC, FMD) (p=<0.01). Type 2 diabetes was associated with reduced heart rate variability and increased subclinical atherosclerosis, with CIMT inversely associated with total power.
Synapse has enriched 10 related papers. Consider them for comparative context: